Skip to main content

Advertisement

Log in

Expression of Myostatin in Intrauterine Growth Restriction and Preeclampsia Complicated Pregnancies and Alterations to Cytokine Production by First-Trimester Placental Explants Following Myostatin Treatment

  • Original Article
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

Preeclampsia (PE) and intrauterine growth restriction (IUGR) are major obstetric health problems. Higher levels of T-helper (Th) 1 (proinflammatory) cytokines have been observed in pregnancies complicated with PE and IUGR; this is in contrast to the predominant Th2 (anti-inflammatory) cytokine environment found in uncomplicated pregnancies. Myostatin is best known as a negative regulator of muscle development and reportedly has a role in fat deposition, glucose metabolism, and cytokine modulation (outside the placenta). Myostatin concentrations in plasma and protein expression in placental tissue are significantly higher in women with PE. Expression of myostatin in IUGR and PE-IUGR and the effect of this protein on the cytokine production from the placenta is unknown. In the current study, significant differences were identified in the expression of myostatin in pregnancies complicated with IUGR, PE, and PE with IUGR. Furthermore, cytokine production by first-trimester placental tissues was altered following myostatin treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Karumanchi SA, Maynard SE, Stillman IE, Epstein FH, Sukhatme VP. Preeclampsia: a renal perspective. Kidney Int. 2005;67(6):2101–2113.

    Article  PubMed  Google Scholar 

  2. Clinical indicator user manual 2012: Obstetrics version 7. RANZ-COG/ACHS Obstetric Clinical Indicators 2011. 2012.

  3. Roberts DJ, Post MD. The placenta in pre-eclampsia and intrauterine growth restriction. J Clin Pathol. 2008;61(12):1254–1260.

    Article  CAS  PubMed  Google Scholar 

  4. Scifres CM, Nelson DM. Intrauterine growth restriction, human placental development and trophoblast cell death. J Physiol. 2009;587(14):3453–3458.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Guo J, Tian T, Lu D, Xia G, Wang H, Dong M. Alterations of maternal serum and placental follistatin-like 3 and myostatin in pre-eclampsia. J Obstet Gynaecol Res. 2012;38(7):988–996.

    Article  CAS  PubMed  Google Scholar 

  6. Hu D, Tian T, Guo J, Wang H, Chen D, Dong M. Decreased maternal and placental concentrations of follistatin-like 3 in gestational diabetes. Clin Chim Acta. 2012;413(5–6):533–536.

    Article  CAS  PubMed  Google Scholar 

  7. Peiris HN, Lappas M, Georgiou HM, et al. Myostatin in the placentae of pregnancies complicated with gestational diabetes mellitus. Placenta. 2015;36(1):1–6.

    Article  CAS  PubMed  Google Scholar 

  8. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member. Nature. 1997;387(6628):83–90.

    Article  CAS  PubMed  Google Scholar 

  9. Lee SJ. Regulation of muscle mass by myostatin. Annu Rev Cell Dev Biol. 2004;20:61–86.

    Article  CAS  PubMed  Google Scholar 

  10. Rodgers BD, Garikipati DK. Clinical, agricultural, and evolutionary biology of myostatin: a comparative review. Endocr Rev. 2008;29(5):513–534.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Hill JJ, Davies MV, Pearson AA, et al. The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J Biol Chem. 2002;277(43):40735–40741.

    Article  CAS  PubMed  Google Scholar 

  12. Lee SJ. Genetic analysis of the role of proteolysis in the activation of latent myostatin. PLoS One. 2008;3(2):e1628.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Peiris HN, Mitchell MD. The expression and potential functions of placental myostatin. Placenta. 2012;33(11):902–907.

    Article  CAS  PubMed  Google Scholar 

  14. Jones RL, Stoikos C, Findlay JK, Salamonsen LA. TGF-beta superfamily expression and actions in the endometrium and placenta. Reproduction. 2006;132(2):217–232.

    Article  CAS  PubMed  Google Scholar 

  15. Mitchell MD, Osepchook CC, Leung KC, McMahon CD, Bass JJ. Myostatin is a human placental product that regulates glucose uptake. J Clin Endocrinol Metab. 2006;91(4):1434–1437.

    Article  CAS  PubMed  Google Scholar 

  16. Antony N, Bass JJ, McMahon CD, Mitchell MD. Myostatin regulates glucose uptake in BeWo cells. Am J Physiol Endocrinol Metab. 2007;293(5):E1296–E1302.

    Article  CAS  PubMed  Google Scholar 

  17. Peiris HN, Ponnampalam AP, Osepchook CC, Mitchell MD, Green MP. Placental expression of myostatin and follistatin-like-3 protein in a model of developmental programming. Am J Physiol Endocrinol Metab. 2010;298(4):E854–E861.

    Article  CAS  PubMed  Google Scholar 

  18. Peiris HN, Salomon C, Payton D, et al. Myostatin is localized in extravillous trophoblast and up-regulates migration. J Clin Endocrinol Metab. 2014;99(11):E2288–E2297.

    Article  CAS  PubMed  Google Scholar 

  19. Myatt L. Placental adaptive responses and fetal programming. J Physiol. 2006;572(pt 1):25–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Regnault TRH, Galan HL, Parker TA, Anthony RV. Placental development in normal and compromised pregnancies - A review. Placenta. 2002;23(suppl 1):S119–S129.

    Article  PubMed  Google Scholar 

  21. Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod. 2003;69(1):1–7.

    Article  CAS  PubMed  Google Scholar 

  22. Huppertz B. Placental pathology in pregnancy complications. Thromb Res 2011;127(suppl 3):S96–S99.

    Article  CAS  PubMed  Google Scholar 

  23. Mayhew TM, Wijesekara J, Baker PN, Ong SS. Morphometric evidence that villous development and fetoplacental angiogenesis are compromised by intrauterine growth restriction but not by pre-eclampsia. Placenta. 2004;25(10):829–833.

    Article  CAS  PubMed  Google Scholar 

  24. Bowen JM, Chamley L, Mitchell MD, Keelan JA. Cytokines of the placenta and extra-placental membranes: biosynthesis, secretion and roles in establishment of pregnancy in women. Placenta. 2002;23(4):239–256.

    Article  CAS  PubMed  Google Scholar 

  25. Sykes L, MacIntyre DA, Yap XJ, Teoh TG, Bennett PR. The Th1: Th2 dichotomy of pregnancy and preterm labour. Mediators Inflammation. 2012;2012:967629.

    Google Scholar 

  26. Challis JR, Lockwood CJ, Myatt L, Norman JE, Strauss JF III, Petraglia F. Inflammation and pregnancy. Reprod Sci. 2009;16(2):206–215.

    Article  CAS  PubMed  Google Scholar 

  27. Mullins E, Prior T, Roberts I, Kumar S. Changes in the maternal cytokine profile in pregnancies complicated by fetal growth restriction. Am J Reprod Immunol. 2012;68(1):1–7.

    Article  CAS  PubMed  Google Scholar 

  28. Gomes CP, Torloni MR, Gueuvoghlanian-Silva BY, Alexandre SM, Mattar R, Daher S. Cytokine levels in gestational diabetes mellitus: a systematic review of the literature. Am J Reprod Immunol. 2013;69(6):545–557.

    CAS  PubMed  Google Scholar 

  29. Raghupathy R, Al-Azemi M, Azizieh F. Intrauterine growth restriction: Cytokine profiles of trophoblast antigenstimulated maternal lymphocytes. Clin Dev Immunol. 2012;2012:734865.

    Article  PubMed  CAS  Google Scholar 

  30. Szarka A, Rigó J Jr, Lázár L, Beko G, Molvarec A. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol. 2010;11:59.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Tosun M, Celik H, Avci B, Yavuz E, Alper T, Malatyalioǧlu E. Maternal and umbilical serum levels of interleukin-6, interleukin-8, and tumor necrosis factor-α in normal pregnancies and in pregnancies complicated by preeclampsia. J Matern Fetal Med. 2010;23(8):880–886.

    Article  CAS  Google Scholar 

  32. Founds SA, Powers RW, Patrick TE, et al. A comparison of circulating TNF-alpha in obese and lean women with and without preeclampsia. Hypertens Pregnancy. 2008;27(1):39–48.

    Article  CAS  PubMed  Google Scholar 

  33. Holcberg G, Huleihel M, Sapir O, et al. Increased production of tumor necrosis factor-α TNF-α by IUGR human placentae. Eur J Obstet Gynecol Reprod Biol. 2001;94(1):69–72.

    Article  CAS  PubMed  Google Scholar 

  34. Wilkes JJ, Lloyd DJ, Gekakis N. Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance. Diabetes. 2009;58(5):1133–1143.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Zhang L, Rajan V, Lin E, et al. Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease. FASEB J. 2011;25(5):1653–1663.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Bonetto A, Penna F, Minero VG, et al. Glutamine prevents myostatin hyperexpression and protein hypercatabolism induced in C2C12 myotubes by tumor necrosis factor-alpha. Amino Acids. 2011;40(2):585–594.

    Article  CAS  PubMed  Google Scholar 

  37. Costelli P, Muscaritoli M, Bonetto A, et al. Muscle myostatin signalling is enhanced in experimental cancer cachexia. Eur J Clin Invest. 2008;38(7):531–538.

    Article  CAS  PubMed  Google Scholar 

  38. Ermolova NV, Martinez L, Vetrone SA, et al. Long-term administration of the TNF blocking drug Remicade (cV1q) to mdx mice reduces skeletal and cardiac muscle fibrosis, but negatively impacts cardiac function. Neuromuscul Disord. 2014;24(7):583–595.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Lowe SA, Brown MA, Dekker GA, et al. Guidelines for the management of hypertensive disorders of pregnancy 2008. Aust N Z J Obstet Gynaecol. 2009;49(3):242–246.

    Article  PubMed  Google Scholar 

  40. Munro SK, Mitchell MD, Ponnampalam AP. Histone deacetylase inhibition by trichostatin A mitigates LPS induced TNFα and IL-10 production in human placental explants. Placenta. 2013;34(7):567–573.

    Article  CAS  PubMed  Google Scholar 

  41. Salomon C, Ryan J, Sobrevia L, et al. Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis. PLoS One. 2013;8(7):e68451.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Blumenstein M, Mitchell MD, Groome NP, Keelan JA. Hypoxia inhibits activin A production by term villous trophoblast in vitro. Placenta. 2002;23(10):735–741.

    Article  CAS  PubMed  Google Scholar 

  43. Lappas M, Permezel M, Rice GE. Release of proinflammatory cytokines and 8-isoprostane from placenta, adipose tissue, and skeletal muscle from normal pregnant women and women with gestational diabetes mellitus. J Clin Endocrinol Metab. 2004;89(11):5627–5633.

    Article  CAS  PubMed  Google Scholar 

  44. Founds SA, Ren D, Roberts JM, Jeyabalan A, Powers RW. Follistatin-Like 3 across gestation in preeclampsia and uncomplicated pregnancies among lean and obese women[published online April 3, 2014]. Reprod Sci. 2014.

  45. Banerjee S, Smallwood A, Moorhead J, et al. Placental expression of interferon-γ (IFN-γ) and its receptor IFN-γR2 fail to switch from early hypoxic to late normotensive development in preeclampsia. J Clin Endocrinol Metab. 2005;90(2):944–952.

    Article  CAS  PubMed  Google Scholar 

  46. Lash GE, Otun HA, Innes BA, et al. Interferon-γ inhibits extravillous trophoblast cell invasion by a mechanism that involves both changes in apoptosis and protease levels. Faseb J. 2006;20(14):2512–2518.

    Article  CAS  PubMed  Google Scholar 

  47. Haider S, Knofler M. Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium. Placenta. 2009;30(2):111–123.

    Article  CAS  PubMed  Google Scholar 

  48. Monzon-Bordonaba F, Vadillo-Ortega F, Feinberg RF. Modulation of trophoblast function by tumor necrosis factor-alpha: a role in pregnancy establishment and maintenance? Am J Obstet Gynecol. 2002;187(6):1574–1580.

    Article  CAS  PubMed  Google Scholar 

  49. De Oliveira LG, Lash GE, Murray-Dunning C, et al. Role of interleukin 8 in uterine natural killer cell regulation of extravillous trophoblast cell invasion. Placenta. 2010;31(7):595–601.

    Article  PubMed  CAS  Google Scholar 

  50. Naruse K, Innes BA, Bulmer JN, Robson SC, Searle RF, Lash GE. Secretion of cytokines by villous cytotrophoblast and extravillous trophoblast in the first trimester of human pregnancy. J Reprod Immunol. 2010;86(2):148–150.

    Article  CAS  PubMed  Google Scholar 

  51. de M-PMI, Vince GS, Flanagan BF, Hart CA, Johnson PM. Localization of IL-4 and IL-4 receptors in the human term placenta, decidua and amniochorionic membranes. Immunology. 1997;90(1):87–94.

    Article  Google Scholar 

  52. Chatterjee P, Kopriva SE, Chiasson VL, et al. Interleukin-4 deficiency inducesmild preeclampsia inmice. J Hypertens. 2013;31(7):1414–1423.

    Article  CAS  PubMed  Google Scholar 

  53. Celik H, Avci B, Alper T. Comparison of maternal serum levels of interleukin-10, interleukin-12, and interleukin-2 in normal and preeclamptic pregnancies. Pregnancy Hypertens. 2012;2(1):39–42.

    Article  PubMed  Google Scholar 

  54. Borekci B, Aksoy H, Al RA, Demircan B, Kadanali S. Maternal serum interleukin-10, interleukin-2 and interleukin-6 in preeclampsia and eclampsia. Am J Reprod Immunol. 2007;58(1):56–64.

    Article  CAS  PubMed  Google Scholar 

  55. Jauniaux E, Gulbis B, Burton GJ. Physiological implications of the materno-fetal oxygen gradient in human early pregnancy. Reprod Biomed Online. 2003;7(2):250–253.

    Article  PubMed  Google Scholar 

  56. Rodesch F, Simon P, Donner C, Jauniaux E. Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy. Obstet Gynecol. 1992;80(2):283–285.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Murray D. Mitchell DSc.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Peiris, H.N., Georgiou, H., Lappas, M. et al. Expression of Myostatin in Intrauterine Growth Restriction and Preeclampsia Complicated Pregnancies and Alterations to Cytokine Production by First-Trimester Placental Explants Following Myostatin Treatment. Reprod. Sci. 22, 1202–1211 (2015). https://doi.org/10.1177/1933719115572482

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719115572482

Keywords

Navigation